To assess the role of tumor necrosis factor-a (TNF-a) in modulating the process of cerebral ischemic injury, we identified TNF-a-producing cells and studied the time course of TNF-a expression, Immunoreactivity for TNF-a ap peared in white matter of the mouse hippocampus as early as 1.5 h following a 30-min global ischemic insult Double stain ing for TNF-a and glial fibrillary acidic protein (GFAP) sug gested that the TNF-a -positive cells are most likely microglia, not astrocytes, TNF-a immunostaining decreased at 6 and 24 h but increased again at 3 days, when pyramidal neurons showed degeneration, Adjacent-section staining for microglia and double staining with GFAP suggested that TNF-a-positive
Several pathophysiologic factors contribute to isch emic brain injury, such as excitotoxicity, intracellular calcium overload, altered gene expression, and reactive oxygen species (Matsuyama et aI., 1993) . Recently, cy tokines also have become a focus of attention (Minami et aI, 1992; Wiessner et aI., 1993; Liu et aI., 1994) . Tumor necrosis factor-a (TNF-a) is a pleiotropic cytokine with diverse functions mediating the inflammatory and im mune responses in injury and repair. TNF-a has been linked to oligodendroglial injury, to cytotoxicity of lipo polysaccharide-stimulated astrocytes, and to astrocytic proliferation in vitro (Robbins et ai., 1987; Selmaj and Raine, 1988) . It enhances leukocyte adherence to endo thelium, probably through activation of adhesion mol ecules such as intercellular adhesion molecule-l (Warren 1990; Mantovani et aI., 1992) . TNF-a activates proco agulant processes (Pober and Cotran, 1990) and stimu lates macrophages to produce other immune mediators (Hori et aI., 1989) .
TNF-a, produced mainly by activated macrophages, also is produced by microglia and astrocytes in culture (Lieberman et aI., 1989; Sawada et ai., 1989; Chung and Benveniste, 1990) . In addition, evidence has been accu mulated that glial cells contribute to a cytokine network in the central nervous system (Benveniste, 1992; Feuer stein et aI., 1994; Rothwell and Hopkins, 1995) . Al though cerebral ischemic injury promotes glial prolifera tion, its effects on the production of cytokines have not been fully elucidated. In addition, the glial source of TNF-a has not been identified in vivo, although TNF-a induction in neurons has been reported after focal cere bral ischemia (Liu et aI., 1994) .
Production of cytokines including TNF-a has been investigated in traumatic brain injury models (Taupin et aI., 1993; Shohami et al 1994) , in which such cytokines are rapidly synthesized in the brain as early as 3 h fol lowing the insult. In cultured astrocytes, a hypoxial reoxygenation insult induces synthesis of cytokines as early as 1.5 h (Maeda et aI., 1994; Matsuo et aI., 1995) . The in vivo time course of cytokine synthesis has not been investigated in the ischemia/reperfusion model.
This study was sought to immunocytochemically de termine the time course and the cellular sources of TNF-a production in the brain following transient global ischemia.
MATERIALS AND METHODS

Animal preparation
A total of 266 male Balb/c mice (25-30 g; Charles River, Yokohama, Japan) underwent the cerebral ischemic insult in this study. One hundred animals were used to examine the relationship between their neurologic status and the hippocam pal injury following cerebral ischemia. The analysis for brain TNF-a immunoreactivity following ischemia was performed with the remaining 166 animals.
Mice were anesthetized lightly by ether inhalation, and ce rebral ischemia was produced by occluding both common ca rotid arteries with microaneurysm clips for 30 min. Rectal tem peratures were maintained at 37.0-37.2°C during the insult and for at least 1 h following the ischemia. The neurologic status of each animal was recorded during the 30-min period of occlu sion. Disturbances of consciousness, piloerection, ptosis, de fective eye closure, jumping, running, rolling, and splayed-out hindlimbs variously were observed. Animals were divided into two groups: (1) comatose (showing disappearance of the right ing reflex) and (2) noncomatose. In some animals CBF was measured by a laser-Doppler apparatus (Neuroscience, Japan) in a middle cerebral artery distribution bilaterally during and for I h following carotid occlusion.
Immunocytochemistry
Animals were perfusion-fixed with periodate lysine paraformaldehyde solution under pentobarbital anesthesia (50 mg/kg body wt) at 1.5 h (n = 5), 6 h (n = 4), 24 h (n = 5), 3 days (n = 5), and 5 days (n = 5) following clip removal.
Sham-operated animals (n = 5) whose carotid arteries were exposed but not clipped were perfused with the same fixative.
The brain was removed and sectioned at 20 J-Lm on a vibratome.
Sections were incubated overnight at 4°C with a 1 :500 dilution of monoclonal anti-mouse TNF-a antibody (Upstate Biotech nology, NY, U.S.A.; lot 12391). They were then stained by the avidin-biotin-peroxidase complex method (Vectastain ABC Kit, Vector, NY, U.S.A.). TNF-a immunoreactivity was iden tified with a diaminobenzidine reaction. To test for specificity, Western blotting and omission and absorption control experi ments were performed. Absorption was carried out using a mixture of primary antibody and recombinant mouse TNF-a (10-6 M; Genzyme, Cambridge, MA, U.S.A.).
Adjacent sections were incubated with a monoclonal anti body against a macrophage (F4/S0, 1:10; Serotec Ltd, U.K.) to detect microglia or were incubated with an anti-GFAP antibody (I :500; Dako, Denmark) to identify astrocytes. Some single sections were doubly stained for TNF-a and GFAP. In this case, GFAP immunoreactivity was detected using fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Vector, Bur lingame, CA, U.S.A.) as a second antibody after TNF-a stain ing and was observed under a fluorescence microscope.
Western analysis
Animals were decapitated after sham operation and at 1.5 h, 24 h, and 3 days following ischemia (5 animals/group), and the hippocampi were removed. Tissue was homogenized with sample buffer containing 2% sodium dodecyl sulfate. Samples containing 9 J-Lg of protein were subjected to 10% polyacryl amide gel electrophoresis in the presence of 0.1 % sodium do decyl sulfate. Protein bands were transferred from the gel to a nitrocellulose membrane using a semidry transfer apparatus and a blotting buffer including 0.192 M glycine and 20% methanol (pH S.4). The membrane then was incubated with a I :500 dilution of primary antiserum and stained by the avidin-J Cereb Blood Flow Metab, Vol. 17, No.5. 1997 biotin-peroxidase complex method as described. Protein deter minations were performed in triplicate with a colorimetric dye binding assay (Bio-Rad, Richmond, CA, U.S.A.). The quanti tative analysis for TNF-a immunoreactivity was carried out using a computerized densitometry system (ATTO Densito graph, ver. 4.0, Japan).
Statistical analysis
TNF-a-immunoreactive cells were counted on 12 sections including hippocampus per animal (five animals in groups at 1.5 h, 24 h, 3 days, and 5 days and four in group at 6 h). Results were expressed as cells per square millimeter ± SD. Statistical analysis of the data was done by an analysis of variance with a post hoc Scheffe test.
RESULTS
Neurologic status
The correlation between neurologic status of mice dur ing ischemia and histologic appearance after clip re moval is shown in Tables 1 and 2. Fifty-three of 100 animals showed loss of the righting reflex during isch emia. Twenty-seven animals of these 53 died during ischemia. Twenty-four of the 26 surviving mice showed hippocampal neuronal degeneration 4 days after isch emia, while 2 did not. Thus, only 24% of animals un dergoing carotid occlusion could be used in immunocy tochemical experiments.
Monitoring CBF during ischemia in a separate group showed a high correlation between neurologic status and CBF decrease ( Fig. 1 ). Carotid occlusion resulted in a bilateral CBF decrease by 10-20% in all comatose ani mals, while noncomatose animals showed a CBF de crease by 40-60% during ischemia.
Immunocytochemistry for TNF-a
Of 166 animals subjected to bilateral carotid ligation, 39 showed coma but survived.
In sham-operated animals, almost no TNF-a was ex pressed in hippocampal cells ( Fig. 2A ). Following isch emia, TNF-a immunoreactivity was found exclusively in the hippocampal formation including the dentate gyrus. Two appearances characterized the immunoreactive cells, one being a round cell with few processes (Fig. 3A , B, and C) and the other a pyramidally shaped cell with many processes (Fig. 3E ). The former TNF-a-positive cells were scattered sparsely in the hippocampal white matter 1.5 h following ischemia, and the latter were found late in the recirculation period at 3 days. The round cell type was found in the pyramidal cell layer at 1 and 3 days after ischemia ( Fig. 3A and B ). TNF-a immuno reactivity also was evident in cells adjoining blood vessel lumina, most like l y endothelial cells ( Fig. 3B ), but was never seen in pyramidal neurons or in granule cells of the dentate gyrus. This immunoreactivity was not seen in sections incubated without the primary antibody or with antibody solution absorbed using recombinant mouse TNF-a, confirming the specific expression of TNF-a in glial cells following ischemic insult ( Fig. 4 ). Double staining for TNF-a and GFAP revealed pyra midally shaped TNF-a-positive cells staining for GFAP at the same time, but also round small TNF-a-positive cells that did not ( Fig. 3C-F ). This indicates that both GFAP-positive astrocytes and another glial cell type, such as microglia, express TNF-a following ischemia.
Time course of TNF -a and microglia staining � The number of cells staining over time for TNF-a or F4/80 in the dorsal hippocampus appear in Figs. 2 and 5. In sham-operated animals, F4/80 antigens were ex pressed in many glial cells in the white matter ( Fig. 2G ). Their morphologic characteristics followed the classic morphology of resting ramified microglia with a number of long, thin processes. After 1.5 h of recirculation, F4/ 80 immunoreactivity was increased in microglia, which showed the morphology of activated microglia with thick short processes, although their number remained largely unchanged ( Fig. 2H ).
TNF-a immunoreactivity was expressed anew in the hippocampus at 1.5 h of reperfusion (Fig. 2B ). The TNF a-positive cells were predominantly distributed in the white matter of CAl and in the molecular layer of the dentate gyrus. The distribution pattem was similar to that of F4/80 immunoreactive microglia ( Fig. 2B and H) . Almost none of the TNF-a-immunopositive cells were labeled by GFAP antibody. These findings indicate that the TNF-a-positive cells at 1.5 h are microglia ( Fig. 3C  and D) .
At 6 and 24 h following ischemia, TNF-a immunore activity was generally reduced in the hippocampus com pared with that seen earlier ( Fig. 2C and D) . The distri bution pattern also was changed. TNF-a-positive mi croglia and endothelial cells had decreased significantly in the whole hippocampus ( Fig. 5 ), while the number of TNF-a-positive round cells within the pyramidal layer had slightly increased.
On the other hand, no further morphologic changes were conspicuous in the microglia during the period be tween 6 and 24 h following ischemia. Some of these microglia still had hypertrophic perikarya and short thick processes and were seen in the pyramidal cell layer ( Fig.  21 and J) .
At 3 days of recirculation, staining for TNF-a again was increased in both the pyramidal layer and the white matter regions such as the stratum oriens, stratum radia tum, and lacunosum moleculare, especially in the CAl sector. Some pyramidal neurons had degenerated in the CAl layer, where many round small cells staining in tensely for TNF-a had accumulated ( Fig. 2E ). In con trast, in the white matter, pyramidally shaped TNF-a positive cells were increased in number and intensity of staining.
The distribution of microglia was very similar to that of TNF-a-positive cells 3 days after the ischemia. Mi croglia increased in number both in the pyramidal layer and in the white matter. The microglia in the pyramidal layer showed amoeboid morphology (Fig. 2K ). How ever, most of the microglia in the white matter had many thick processes. Double-staining immunocytochemistry revealed that TNF-a-positive cells in the pyramidal layer did not stain for GFAP, while most TNF-a cells in the white matter also stained for GFAP, indicating that these latter cells were astrocytes ( Fig. 3E and F) .
At 5 days of recirculation, almost no staining for TNF-a was seen in the hippocampus, although the mi croglia had continued to accumulate in the pyramidal
FIG. 1. Regional CBF during 30 min of bilateral common carotid occlusion and 30 min of reperfusion in comatose and noncoma tose mice. Animals were operated initially under halothane an esthesia. Regional CBF was determined by laser-Doppler flow metry. The tip of the probe was placed bilaterally on the intact skull over the ischemic cortex (1 mm anterior and 4.5 mm lateral from bregma). The individual data are presented as mean values of right and left CBF, e, comatose mice (n = 6); 0, noncomatose mice (n = 5). There are significant differences between groups (*p < 0.01).
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FIG. 2. Distribution and time course of immunoreactivity for tumor necrosis factor-a (TNF-a) (A-F) and F4/80 (G-L) in mouse hippo campus following ischemia. Sections were prepared from sham-operated control brain (c) and following 30 min of ischemia at the indicated interval. In the control brain, no TNF-a immunoreactivity is seen (A), while many F4/80-positive ramified microglia are apparent (G). TNF-a was induced anew in small cells at 1.5 h (B). Accumulation of immunoprecipitate is reduced at 6 h (C) and 24 h (D) and is increased again at 3 days (E). Adjacent sections of each period show a similar intensity profile of staining for microglia (H-K). At 5 days, however, almost no TNF-a is observed (F), while many activated microglia are evident in the hippocampus (L). Bar = 100 IJm. layer, where degeneration of neurons was clearly evident ( Fig. 2F and L) .
Densities of TNF-a-positive cells and microglia (cells/1 mm 2 ) in the CAl region of the hippocampus were 2.5 ± 2.9 and 108.3 ± 20.8 in controls, 148.4 ± 25.7 and 162.5 ± 3.5 at 1.5 h, 72.0 ± 8.4 and 152.0 ± 18.2 at 6 h, 66.3 ± 25.6 and 129.0 ± 16.7 at 24 h, 185.0 ± 33.4 and 310.0 ± 51.8 at 3 days, and 16.3 ± 4.3 and 278.0 ± 41.3 at 5 days, respectively.
Western analysis
A characteristic accumulation of immunoreactive TNF-a was evident as a single band of molecular mass 17 kDa (Fig. 6) . The signal was transiently increased during 1.5 hand 3 days after ischemia. The densitometric analysis revealed that the signal intensity was signifi cantly stronger at 1.5 h and at 3 days than that of control (p < 0.01), but did not differ at 24 h from that of control (Fig. 7) . This expression pattern was in agreement with the biphasic expression of TNF-a positivity in cells of the hippocampus following the ischemic insult. 
DISCUSSION
Cellular source of TNF-a
The present results clearly demonstrate that TNF-a was expressed in the glial cells of the hippocampus fol lowing transient cerebral ischemia, while only very low levels of TNF-a were found in the same structure in sham-operated mice. The pattern of expression induced by an ischemic insult included a very early transient profile with a maximum increase in immunopositive cells taking place by the first day following ischemia and a late transient profile occurring 3 days following isch emia. Double staining with GFAP revealed that the cel lular source of TNF-a at an early period in the hippo- campus was more likely microglia than GFAP-positive astrocytes, and the sources in the late period were both astrocyte and microglia. Previous in vitro studies have shown that TNF-a is synthesized by brain cells such as microglia (Giulian et aI., 1986; Frei et aI., 1987; Sawada et aI., 1989) and astrocytes (Lieberman et aI., 1989; Chung and Benveniste, 1990) . The present data are in agreement with the results in culture mentioned already and further reveal a biphasic expression of TNF-a during reperfusion by these two cell types. Previous studies have suggested that the cellular source of cytokines, including TNF-a, following trau matic injury included invading monocytes and neutro phils, as well as resident brain cells (Woodroofe et aI., 1991; Taupin et aI., 1993) . However, this study showed no histologic evidence for such inflammatory cell infil tration in the hippocampus early after the insult. On the other hand, recent studies have indicated neurons as pos sible cellular sources of TNF-a following surgical trau matic lesions in mice (Tchelingerian et aI., 1993) and persistent focal ischemia in rats (Liu et aI., 1994) . No neuronal TNF-a protein expression was demonstrated in the brain following transient global ischemia in this study. Taken together, the investigations suggest that various cell types including glia and neurons have a ca pacity to produce TNF-a, depending on specific charac teristics of the injury.
Early production of TNF-ex
The present study showed a very early production of TNF-a by microglia following the ischemic insult. The intensity of immunoreactivity peaked at 1.5 h and was already declining at 6 h. Similar TNF-a response profiles have been reported in cultured microglia or astrocytes stimulated with lipopolysaccharide (Sawada et aI., 1989; Sharif et aI., 1993) , in traumatized brains (Young et aI., 1992; Shohami et aI., 1994) , and in ischemic brain . In a model of ischemia/reperfusion injury, Minami et al. (1992) recently have demonstrated an early (30-240 min) induction of mRNA coding for interleu kin-l 13 in cerebral cortex, striatum, and hippocampus fol lowing transient forebrain ischemia. The rapid activation of the cytokine gene by ischemia shown in this study and others suggests that immediate early genes such as c-fos and nuclear factor-KB may be important in initiating the cytokine metabolic cascade (Schreck et aI., 1991; Kaltschmidt et ai, 1994) . On the other hand, the rapid decline of brain cytokine levels despite continued pres ence of glial cells suggests the operation of an endog enous control system producing specific cytokine inhibi tors (Dinarello, 1992) and/or other potential anti inflammatory factors such as transforming growth factor-13 (Morganti-Kossmann et aI., 1992) .
Both astrocytes and microglia proliferate in the injured area after an ischemic insult. The mouse model of tran sient global ischemia used in this study can produce hip pocampal neuronal death similar to delayed neuronal death in the rat and gerbil models (Matsuyama et aI., 1994a (Matsuyama et aI., , 1995 . In such models, the number of GFAP positive astrocytes increases throughout the hippocam pus. However, this glial response appears relatively late in the recirculation period, some 24-48 h after ischemia. In contrast, microglial activation becomes visible within 30 min of reperfusion according to the lectin reaction (Morioka et aI., 1991) . It is well known that resting mi croglia rapidly transform to an activated state in response to a wide range of injuries (Gehrmann et aI., 1995) . Mi croglial activation is apparent as proliferation and re cruitment to the site of injury, as well as morphologic, immunophenotypic, and functional changes. The last cat egory may include release of mediator substances includ ing cytotoxic compounds such as reactive oxygen inter mediates or proteases (Colton and Gilbert, 1987; Thery et aI., 1991; Matsuyama et aI., 1994b) as well as inflam matory cytokines such as interleukin-l, interferon-)" or TNF-a (Giulian and Baker, 1985; Giulian et aI., 1986; Sawada et aI., 1989 Sawada et aI., , 1990 . In this study, we showed rapid morphologic change of microglia within 1.5 h in the postischemic hippocampus and suggest that these ac tivated microglia produce TNF-a.
Astrocytes also produced TNF-a, but the production of TNF-a by astrocytes lagged 1-3 days behind produc tion by microglia in the postischemic hippocampus. This interval seen between microglial and astrocytic produc tion of the cytokine is in agreement with in vitro results (Sawada et aI., 1989) .
Function of TNF-ff
The role of TNF-cx in ischemic brain injury has not yet been fully elucidated. TNF-cx has been shown to cause oligodendrocytic damage, suggesting an important role of TNF-cx in the demyelination of the multiple sclerosis model, experimental autoimmune encephalomyelitis (Robbins et aI., 1987; Selmaj and Raine, 1988; Hofman et aI., 1989) . It activates endothelium to bring about leu kocyte adherence and procoagu1ant processes (Pober and Cotran, 1990; Warren, 1990; Montovani et aI., 1992) . Administration of TNF-cx in brain ischemia has been reported to produce significant neutrophil adherence and accumulation in capillaries and small blood vessels (Liu et aI., 1994) . Since reducing circulating neutrophil levels or their adhesion to blood vessels can significantly re duce ischemic damage, these data suggest that TNF-cx contributes to increased sensitivity and risk in ischemic brain injury. However, it also may regulate other media tors essential to cell defense (Hori et aI., 1989) . TNF-cx stimulates the expression of nerve growth factor in a variety of cell types including fibroblasts, glioblastoma cells, and astrocytes (Hattori et aI., 1993) , which may contribute to neuronal survival in and around the isch emic site. TNF-cx induces manganese superoxide dismu tase in a variety of cells including neurons; the enzyme may proteq.t against ischemic neuronal injury by reduc ing reactive oxygen intermediates (Matsuyama et aI., 1994b) . These findings may explain the target cell dependent function of TNF-cx in the pathophysiology of brain injury.
Both astrocytes and microglia produce TNF-cx; how ever, this study showed that their spatial and temporal expression was different. It remains unclear whether TNF-cx produced by microglia has the same functions as that produced by astrocytes in ischemic neuronal injury. TNF-cx may be both a trigger and a component of the documented cytokine cascade (Abbas et aI., 1991) . We postulate that the following sequence of events may oc cur in delayed neuronal death in the hippocampus fol lowing transient global ischemia. Ischemic insult triggers microglia to secrete TNF-cx, which activates astrocytes to produce other cytokines such as interleukin-6 and granu locyte-monocyte colony-stimulating factor. Subsequent production of TNF-cx by activated astrocytes may facili tate neuronal injury or survival of CAl' The microglia accumulating in the injured pyramidal layer are activated and may initiate phagocytosis with TNF-cx production. Recent studies have shown glial contribution to excito toxic neuronal cell death in the hippocampus (Tsirka et aI., 1995) . Some proteases such as tissue plasminogen activator produced by microglia have been proposed as mediators of apoptotic cell death in the hippocampus (Gehrmann et aI., 1995) . TNF-cx also is known to induce apoptosis through its receptor (Laster et aI., 1988; Cleve land and Ihle, 1995) . Thus, the later-expressed TNF-cx J Cereb Blood Flow Metab, Vol. 17, No. 5, 1997
but not the earlier-expressed one may contribute to cell death in CAl following the transient cerebral ischemia.
In conclusion, we have demonstrated in vivo that glial cells contribute to TNF-cx synthesis following cerebral ischemia. Induction of TNF-cx in microglia occurs rap idly and operates at long distance, suggesting the in volvement of fast and remote signaling mechanisms. In contrast to microglia, astrocytes expressed TNF-cx only later when they visibly proliferated to surround the ad vanced ischemic lesion. It may be very difficult to elu cidate whether TNF-cx is beneficial or harmful in isch emic brain injury, because its action differs from cell to cell. The capacity for glial cells to react to injury by expressing the cytokine appears to be time restricted, a factor that must be considered in future neuroimmuno logic experiments studying cellular mechanisms in volved in ischemic brain injury.
